Introduction to Optimizing Clinical Trial Design In Brain Cancer Other Cancer Types
If you are looking for information about Optimizing Clinical Trial Design In Brain Cancer Other Cancer Types, you have come to the right place. Evanthia Galanis, MD, professor of oncology, Mayo Clinic, discusses how to best
Optimizing Clinical Trial Design In Brain Cancer Other Cancer Types Comprehensive Overview
Johns Hopkins neurosurgeon Chetan Bettegowda, M.D., Ph.D., discusses when The blood–brain barrier (BBB) represents one of the most critical and complex obstacles in QIMR Berghofer's next generation immunotherapy for
Brain cancer
Summary & Highlights for Optimizing Clinical Trial Design In Brain Cancer Other Cancer Types
- Bruce Johnson, MD, from Dana-Farber
- Stephanie Stahl reports.
- This interactive webinar is presented by Dr. Timothy Cloughesy. Dr. Cloughesy discusses the
- Slides for this presentation are available on Dana-Farber's Slideshare page: ...
- Friends of
We hope this detailed breakdown of Optimizing Clinical Trial Design In Brain Cancer Other Cancer Types was helpful.
